Compare CVE & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVE | GEHC |
|---|---|---|
| Founded | 2009 | 1892 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Computer Software: Prepackaged Software |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6B | 35.8B |
| IPO Year | N/A | 2022 |
| Metric | CVE | GEHC |
|---|---|---|
| Price | $23.21 | $70.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $30.50 | ★ $90.83 |
| AVG Volume (30 Days) | ★ 15.5M | 2.8M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 2.70% | 0.20% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | $5.69 | $4.50 |
| P/E Ratio | $18.07 | ★ $15.45 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $10.23 | $57.65 |
| 52 Week High | $24.06 | $89.77 |
| Indicator | CVE | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.28 | 27.74 |
| Support Level | $16.27 | $69.64 |
| Resistance Level | $23.39 | $74.09 |
| Average True Range (ATR) | 0.70 | 2.06 |
| MACD | -0.05 | -1.17 |
| Stochastic Oscillator | 69.74 | 9.52 |
Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).